Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-016812
Filing Date
2021-04-22
Accepted
2021-04-22 19:22:39
Documents
2
Period of Report
2021-04-22

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 5459
2 EX-24 DOCUMENT attachment1.htm EX-24 4004
  Complete submission text file 0000899243-21-016812.txt   10875
Mailing Address C/O GLOBAL BLOOD THERAPEUTICS, INC. 400 EAST JAMIE COURT, SUITE 101 SOUTH SAN FRANCISCO CA 94080
Business Address
Radovich Peter (Reporting) CIK: 0001650131 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40356 | Film No.: 21846291

Mailing Address 8000 JARVIS AVENUE SUITE 204 NEWARK CA 94560
Business Address 8000 JARVIS AVENUE SUITE 204 NEWARK CA 94560 (510) 953-5559
Rain Therapeutics Inc. (Issuer) CIK: 0001724979 (see all company filings)

EIN.: 821130967 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations